Reaction Details Report a problem with these data
Target
Bromodomain-containing protein 4 [42-168]
Ligand
BDBM318524
Substrate
n/a
Meas. Tech.
AlphaScreen Assay A2
IC50
<100±n/a nM
Citation
 Combs, AP; Sparks, RB; Maduskuie, Jr., TP; Rodgers, JD Tricyclic heterocycles as BET protein inhibitors US Patent  US10464947 Publication Date 11/5/2019 
Target
Name:
Bromodomain-containing protein 4 [42-168]
Synonyms:
BRD4 | BRD4 BD1 (aa 42-168) | BRD4_HUMAN | Bromodomain-containing protein 4 Bromo Domain 1 | HUNK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
15054.68
Organism:
Homo sapiens (Human)
Description:
O60885[42-168]
Residue:
127
Sequence:
STNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE
  
Inhibitor
Name:
BDBM318524
Synonyms:
7-(3,5-Dimethylisoxazol-4-yl)-4-ethyl-4-pyridin-2-yl-4,5-dihydroimidazo[1,5,4-de][1,4]benzoxazin-2(1H)-one 2,2,2-trifluoroacetate | US10464947, Example 70 | US11498926, Example 70 | US9624241, Example 70
Type:
Small organic molecule
Emp. Form.:
C21H20N4O3
Mol. Mass.:
376.4085
SMILES:
CCC1(COc2c(ccc3[nH]c(=O)n1c23)-c1c(C)noc1C)c1ccccn1 |(.54,4.59,;.94,3.11,;-.15,2.02,;-1.48,1.25,;-1.48,-.29,;-.15,-1.06,;-.15,-2.6,;1.18,-3.37,;2.52,-2.6,;2.52,-1.06,;3.85,-.29,;2.72,1.25,;3.49,2.58,;1.18,1.25,;1.18,-.29,;-1.48,-3.37,;-2.95,-2.9,;-3.72,-1.56,;-3.85,-4.14,;-2.95,-5.39,;-1.48,-4.91,;-.15,-5.68,;-1.24,3.11,;-.84,4.59,;-1.93,5.68,;-3.42,5.28,;-3.81,3.8,;-2.73,2.71,)|
Structure:
Search PDB for entries with ligand similarity: